BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21394985)

  • 1. [Valproate-induced hyperammononemic encefalopathy].
    Scarano V; Bellarosa I; Bertogliatti S; Terracciano AM; Orlando V
    Recenti Prog Med; 2010 Dec; 101(12):480-2. PubMed ID: 21394985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A valproate-induced encephalopathy without hyperammonemia].
    Parize P; Beuret P; Fischer C
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1084-5. PubMed ID: 18029137
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate-induced hyperammonemia and seizures: perioperative concerns.
    Garg R; Sunder RA
    Paediatr Anaesth; 2011 Oct; 21(10):1084-5. PubMed ID: 21981101
    [No Abstract]   [Full Text] [Related]  

  • 5. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC; Huang MC; Liu HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severe valproate overdose with complete recovery in a newborn.
    Grynnerup A; Fernández IS; Hernández JC; Martínez AD; López JM; García-Alix A
    J Child Neurol; 2012 Aug; 27(8):1072-6. PubMed ID: 22433424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
    Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced hyperammonemic encephalopathy: a brief review.
    Lewis C; Deshpande A; Tesar GE; Dale R
    Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valproate-caused encephalopathy].
    Thygesen KS; Wolf P
    Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydipsia with normal natremia induced by Valproic Acid.
    Guaiana G; Eyrek C; Mariconda G
    Aust N Z J Psychiatry; 2006 Sep; 40(9):815-6. PubMed ID: 16911759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.